Oncotarget is medical journal founded in 2010 by Dr. Mikhail Blagosklonny. This journal is a multidisciplinary platform that publishes papers on a weekly basis. Oncotarget is a peer reviewed journal with free-access.
The leadership of Oncotarget
Dr. Mikhail Blagosklonny founded this journal together his colleague Andrei V. Gudkov from the Roswell Park Cancer Institute. These two professionals serve as the senior editors of Oncotarget. Dr. Mikhail is a cancer specialist and a professor at the famed Roswell Park Cancer Institute. This scientist has published various research papers in Oncotarget and other journals. He has authored close to 270 articles and has more than 25,000 citations. Dr. Mikhail’s recent hypothesis is that Rapamycin could be used to extend a person’s life. Some of the other editors who work at Oncotarget include:
• Frederick Alt of Harvard Medical School
• Ronald A. DePinho of the University of Texas
• Brain J. Druker of Oregon Health Science, Portland
• Arthur B. Pardee of Harvard University
• Bert Vogelstein, Johns Hopkins University
Andrei V. Gudkov is a researcher at the Roswell Park Cancer Institute. He is the chairman of the division of Cell Stress Biology. He helped Dr. Mikhail set up Oncotarget with the aim of promptly disseminating research findings to the general public. He has published and edited various articles that were later posted on Oncotarget. Andrei has published a total of 135 papers and has more than 27 patented products. His efforts and those of his colleague are responsible for the success of this peer-reviewed medical journal. This journal is in charge of revealing immense knowledge on various topics and discoveries. Under their management, Oncotarget has been able to stand out as a journal that promotes both local and international research works.
Materials published by Oncotarget
Aside from oncology, Oncotarget publishes other papers in the fields of endocrinology, pharmacology, cell biology, cardiology, metabolism, and neuroscience. Additionally, Oncotarget also publishes articles on aging and gerotarget. The Code of Conduct for Journal Publishers and COPE Code of Conduct and Best Practice Guidelines for Journal Editors is the one that governs Oncotarget. Apart from research papers, Oncotarget also publishes medical articles and book chapters.
To know more visit @: www.linkedin.com/in/mikhail-blagosklonny-91abb531/